Nuzenio

Aim Immunotech Reports

Aim Immunotech Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

AIM ImmunoTech Q2 loss widens to $3.8M, EPS misses estimates - scanx.tradescanx.trade · Mon, 10 Aug 2026 13:48:48 GMTAIM ImmunoTech Reports Completion of Phase 2 Ampligen Dosing in Metastatic Pancreatic Cancer Trial, Advances Phase 3 Planning - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:47:00 GMTAIM Completes Pancreatic Cancer Study Dosing; Phase 3 Planned - Stock TitanStock Titan · Mon, 10 Aug 2026 12:36:00 GMTAIM ImmunoTech (NYSE: AIM) returns to positive equity after new financings - Stock TitanStock Titan · Fri, 07 Aug 2026 20:36:50 GMTAIM ImmunoTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 20:36:00 GMTAIM ImmunoTech (AIM) inks $1.5M manufacturing pact for Ampligen - Stock TitanStock Titan · Thu, 06 Aug 2026 21:23:31 GMTAIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:33:00 GMT

Timeline

Mon, 10 Aug 2026 13:48:48 GMTAIM ImmunoTech Q2 loss widens to $3.8M, EPS misses estimates - scanx.trade
Mon, 10 Aug 2026 12:47:00 GMTAIM ImmunoTech Reports Completion of Phase 2 Ampligen Dosing in Metastatic Pancreatic Cancer Trial, Advances Phase 3 Planning - Quiver Quantitative
Mon, 10 Aug 2026 12:36:00 GMTAIM Completes Pancreatic Cancer Study Dosing; Phase 3 Planned - Stock Titan
Fri, 07 Aug 2026 20:36:50 GMTAIM ImmunoTech (NYSE: AIM) returns to positive equity after new financings - Stock Titan
Fri, 07 Aug 2026 20:36:00 GMTAIM ImmunoTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Thu, 06 Aug 2026 21:23:31 GMTAIM ImmunoTech (AIM) inks $1.5M manufacturing pact for Ampligen - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Aim Immunotech Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.